Is there really a clinical difference in surfactant preparations?-Reference-Cited by-同舟云学术

Is there really a clinical difference in surfactant preparations?

Published:2010-09-29 Issue:10 Volume:30 Page:698-698
ISSN:0743-8346
Container-title:Journal of Perinatology
language:en
Short-container-title:J Perinatol

Author:

Fujii Alan

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,Pediatrics, Perinatology, and Child Health

Link

http://www.nature.com/articles/jp201090.pdf

Reference7 articles.

1. Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S . Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol advance online publication 25 March 2010; doi: 10.1038/jp.2010.20.

2. Fujii A, Allen R, Doros G, O’Brien S . Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome. J Perinatol advance online publication 25 March 2010; doi: 10.1038/jp.2010.21.

3. Holm B, Cummings JJ . Is there evidence for a mortality difference between exogenous surfactant preparations in neonatal RDS? J Appl Res 2008; 8 (2): 78–83.

4. Cogo PE, Facco M, Simonato M, Verlato G, Rondina C, Baritussio A et al. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics 2009; 124 (5): e950–e957. Epub 2009.

5. Fujii AM, Bailey J, Doros G, Sampat K, Sikes NC, Mason M et al. Cerebral blood flow responses to beractant and poractant administration. J Neonatal-Perinatal Medicine 2009; 2: 27–34.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions;Soft Matter;2021